Verrica Pharmaceuticals Inc.
VRCA
$6.84
$0.6310.15%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -17.83M | -17.89M | -26.01M | -48.60M | -65.99M |
| Total Depreciation and Amortization | 767.00K | 781.00K | 844.00K | 1.00M | 1.14M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 6.63M | 5.73M | 8.42M | 9.52M | 11.24M |
| Change in Net Operating Assets | -3.69M | -6.25M | -12.35M | -9.26M | -48.00K |
| Cash from Operations | -14.11M | -17.63M | -29.10M | -47.34M | -53.66M |
| Capital Expenditure | -- | -- | 0.00 | -16.00K | -27.00K |
| Sale of Property, Plant, and Equipment | -- | -- | 8.00K | 8.00K | 8.00K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | 8.00K | -8.00K | -19.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -44.26M | -48.20M | -12.57M | -8.80M | -4.83M |
| Issuance of Common Stock | 50.07M | 50.07M | 42.50M | 42.50M | 42.65M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -429.00K | -420.00K | -2.70M | -2.88M | -3.50M |
| Cash from Financing | 5.38M | 1.45M | 27.23M | 30.82M | 34.33M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -8.73M | -16.18M | -1.86M | -16.53M | -19.34M |